ATE288484T1 - Transgene nicht-menschliche tiere ohne prionprotein - Google Patents
Transgene nicht-menschliche tiere ohne prionproteinInfo
- Publication number
- ATE288484T1 ATE288484T1 AT92923728T AT92923728T ATE288484T1 AT E288484 T1 ATE288484 T1 AT E288484T1 AT 92923728 T AT92923728 T AT 92923728T AT 92923728 T AT92923728 T AT 92923728T AT E288484 T1 ATE288484 T1 AT E288484T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- prion protein
- date
- sec
- animals
- Prior art date
Links
- 241001465754 Metazoa Species 0.000 title abstract 3
- 230000009261 transgenic effect Effects 0.000 title abstract 3
- 102000029797 Prion Human genes 0.000 title abstract 2
- 108091000054 Prion Proteins 0.000 title abstract 2
- 208000024777 Prion disease Diseases 0.000 abstract 2
- 230000008685 targeting Effects 0.000 abstract 2
- 102100025818 Major prion protein Human genes 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 210000004102 animal cell Anatomy 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 210000004748 cultured cell Anatomy 0.000 abstract 1
- 230000006801 homologous recombination Effects 0.000 abstract 1
- 238000002744 homologous recombination Methods 0.000 abstract 1
- 208000008864 scrapie Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0276—Knock-out vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/30—Bird
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/02—Animal zootechnically ameliorated
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0306—Animal model for genetic diseases
- A01K2267/0318—Animal model for neurodegenerative disease, e.g. non- Alzheimer's
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0337—Animal models for infectious diseases
- A01K2267/0343—Animal model for prion disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Environmental Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Plant Pathology (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US79250991A | 1991-11-14 | 1991-11-14 | |
PCT/EP1992/002631 WO1993010227A1 (en) | 1991-11-14 | 1992-11-16 | Transgenic animals lacking prion proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE288484T1 true ATE288484T1 (de) | 2005-02-15 |
Family
ID=25157140
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT92923728T ATE288484T1 (de) | 1991-11-14 | 1992-11-16 | Transgene nicht-menschliche tiere ohne prionprotein |
Country Status (8)
Country | Link |
---|---|
US (1) | US5698763A (de) |
EP (1) | EP0613495B1 (de) |
AT (1) | ATE288484T1 (de) |
DE (1) | DE69233477T2 (de) |
ES (1) | ES2237747T3 (de) |
HK (1) | HK1013841A1 (de) |
SG (1) | SG47979A1 (de) |
WO (1) | WO1993010227A1 (de) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5565186A (en) * | 1994-05-13 | 1996-10-15 | The Regents Of The University Of California | Method of detecting prions in a sample and transgenic animal used for same |
US5908969A (en) * | 1994-05-13 | 1999-06-01 | The Regents Of The University Of California | Method of detecting prions in a sample and transgenic animal used for same |
US6020537A (en) * | 1994-05-13 | 2000-02-01 | The Regents Of The University Of California | Prion protein standard and method of making same |
US5792901A (en) * | 1994-05-13 | 1998-08-11 | The Regents Of The University Of California | Detecting prions in a sample and prion preparation and transgenic animal used for same |
US6008435A (en) * | 1994-05-13 | 1999-12-28 | The Regents Of The University Of California | Detecting cow, sheep and human prions in a sample and transgenic mice used for same |
EP1416280A3 (de) * | 1995-09-14 | 2005-08-10 | The Regents of the University of California | Antikörper spezifisch für natives PrPsc |
US5834593A (en) * | 1996-11-05 | 1998-11-10 | The Regents Of The University Of California | Soluble form of PrPSC which is insoluble in native form |
US6221614B1 (en) | 1997-02-21 | 2001-04-24 | The Regents Of The University Of California | Removal of prions from blood, plasma and other liquids |
US6720355B2 (en) | 1997-02-21 | 2004-04-13 | The Regents Of The University Of California | Sodium dodecyl sulfate compositions for inactivating prions |
US5891641A (en) * | 1997-02-21 | 1999-04-06 | The Regents Of The University Of California | Assay for disease related conformation of a protein |
US6617119B2 (en) | 1997-02-21 | 2003-09-09 | The Regents Of The University Of California | Assay for specific strains of multiple disease related conformations of a protein |
US6620629B1 (en) | 1997-02-21 | 2003-09-16 | The Regents Of The University Of California | Method for detecting prions |
US6719988B2 (en) | 1997-02-21 | 2004-04-13 | The Regents Of The University Of California | Antiseptic compositions for inactivating prions |
JP2002514224A (ja) | 1997-06-02 | 2002-05-14 | ザ レジェンツ オブ ザ ユニバーシティー オブ カリフォルニア | プリオン蛋白質調節因子(ppmf)およびプリオン抵抗性動物 |
US5962669A (en) * | 1997-06-02 | 1999-10-05 | The Regents Of The University Of California | Nucleic acid encoding prion protein variant |
US6214565B1 (en) | 1998-10-09 | 2001-04-10 | The Regents Of The University Of California | Assay for disease related conformation of a protein and isolating same |
US5977324A (en) * | 1998-02-20 | 1999-11-02 | The Regents Of The University Of California | Process for concentrating protein with disease-related conformation |
US6548737B1 (en) | 1998-05-15 | 2003-04-15 | Barnes-Jewish Hospital | Transgenic mice deficient in natural killer cells |
WO2000021362A1 (en) * | 1998-10-09 | 2000-04-20 | The Regents Of The University Of California | VIABLE PrP (PRION PROTEIN) TRANSGENIC ANIMALS AND METHODS OF USE |
EP1141245B1 (de) * | 1998-12-22 | 2005-11-09 | The Regents Of The University Of California | Somatische zellen mit funktionsunfähigem prp gen und verwendungsverfahren |
US7569660B1 (en) | 1999-06-09 | 2009-08-04 | The University Of Chicago | Recombinant prion-like proteins and materials comprising same |
AU7491800A (en) * | 1999-09-15 | 2001-04-17 | Therapeutic Human Polyclonals, Inc. | Immunotherapy with substantially human polyclonal antibody preparations purifiedfrom genetically engineered birds |
US7414170B2 (en) * | 1999-11-19 | 2008-08-19 | Kirin Beer Kabushiki Kaisha | Transgenic bovines capable of human antibody production |
US7820878B2 (en) | 1999-11-19 | 2010-10-26 | Kyowa Hakko Kirin Co., Ltd. | Production of ungulates, preferably bovines that produce human immunoglobulins |
US7074983B2 (en) | 1999-11-19 | 2006-07-11 | Kirin Beer Kabushiki Kaisha | Transgenic bovine comprising human immunoglobulin loci and producing human immunoglobulin |
CA2402787A1 (en) * | 2000-03-24 | 2001-10-04 | Jose Cibelli | Prion-free transgenic ungulates |
WO2002051997A1 (en) | 2000-12-22 | 2002-07-04 | Aurox Llc | Methods for cloning mammals using reprogrammed donor chromatin or donor cells |
US7491534B2 (en) | 2000-12-22 | 2009-02-17 | Kirin Holdings Kabushiki Kaisha | Methods for altering cell fate to generate T-cells specific for an antigen of interest |
US20020142397A1 (en) | 2000-12-22 | 2002-10-03 | Philippe Collas | Methods for altering cell fate |
WO2002074935A2 (en) * | 2001-03-21 | 2002-09-26 | Geron Corporation | Use of telomerase reverse transcriptase to create homozygous knockout animals |
US20020194635A1 (en) * | 2001-03-30 | 2002-12-19 | Dunne Patrick W. | Transgenic animals resistant to transmissible spongiform encephalopathies |
US20030229910A1 (en) * | 2002-04-17 | 2003-12-11 | Richard Metz | Short fragment homologous replacement to provide BSE resistant cattle |
RU2384059C2 (ru) | 2002-11-08 | 2010-03-20 | Киова Хакко Кирин Ко., Лтд. | Трансгенные копытные животные, имеющие пониженную активность прионного белка, и их применения |
US20050085291A1 (en) * | 2003-10-15 | 2005-04-21 | Kenilworth Systems Corporation | Method and system for supplying funds to a terminal for remote wagering |
KR101141733B1 (ko) | 2003-12-09 | 2012-05-03 | 재단법인서울대학교산학협력재단 | 프리온을 코딩하는 유전자가 적중된 형질전환 복제 소 및이의 생산 방법 |
WO2005104835A2 (en) | 2004-04-22 | 2005-11-10 | Kirin Beer Kabushiki Kaisha | Transgenic animals and uses thereof |
MX2009005277A (es) * | 2006-11-20 | 2009-05-28 | Octagene Gmbh | Ablacion genetica de celulas del gen prp utilizando una estrategia de trampa promotora dirigida para la produccion de proteinas recombinates sin suero como terapeuticos. |
JO3244B1 (ar) | 2009-10-26 | 2018-03-08 | Amgen Inc | بروتينات ربط مستضادات il – 23 البشرية |
US11554130B2 (en) | 2019-01-11 | 2023-01-17 | GlycoScience Research, Inc. | Treatment of neurodegenerative disease with ovine GM1 gangliosidosis GM1 ganglioside |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4736866B1 (en) * | 1984-06-22 | 1988-04-12 | Transgenic non-human mammals | |
ATE201444T1 (de) * | 1985-03-21 | 2001-06-15 | Johnston Stephen Ph D | Vom parasit abgeleiteter widerstand |
CN1030255A (zh) * | 1987-04-14 | 1989-01-11 | 路明尼斯有限公司 | 转移基因的动物 |
EP0351921A3 (de) * | 1988-07-22 | 1991-07-17 | Merck & Co. Inc. | Modifizierter beta-adrenergischer Rezeptor |
DE68928914T2 (de) * | 1988-08-04 | 1999-09-09 | Amrad Corp. Ltd. | (in vitro)-vermehrung von embryonalen stammzellen unter verwendung von leukämie-inhibitionsfaktor (lif) |
EP0950707B1 (de) * | 1989-07-25 | 2009-02-18 | Cell Genesys, Inc. | Homologe Rekombination für universelle Donorzellen und chimerische Säugetierzellen |
EP0424044A1 (de) * | 1989-10-16 | 1991-04-24 | Merck & Co. Inc. | Rinderwachstumshormone exprimierende Transgen-Hühner |
EP0424027A1 (de) * | 1989-10-16 | 1991-04-24 | Merck & Co. Inc. | Vektoren zur Erzeugung von Transgen-Hühnern |
US5155218A (en) * | 1990-05-08 | 1992-10-13 | Neurogenetic Corporation | Dna encoding human 5-ht1d receptors |
US5565186A (en) * | 1994-05-13 | 1996-10-15 | The Regents Of The University Of California | Method of detecting prions in a sample and transgenic animal used for same |
-
1992
- 1992-11-16 ES ES92923728T patent/ES2237747T3/es not_active Expired - Lifetime
- 1992-11-16 DE DE69233477T patent/DE69233477T2/de not_active Expired - Lifetime
- 1992-11-16 WO PCT/EP1992/002631 patent/WO1993010227A1/en active IP Right Grant
- 1992-11-16 EP EP92923728A patent/EP0613495B1/de not_active Expired - Lifetime
- 1992-11-16 AT AT92923728T patent/ATE288484T1/de active
- 1992-11-16 SG SG1996005840A patent/SG47979A1/en unknown
- 1992-11-26 US US08/244,010 patent/US5698763A/en not_active Expired - Lifetime
-
1998
- 1998-12-23 HK HK98115213A patent/HK1013841A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO1993010227A1 (en) | 1993-05-27 |
EP0613495A1 (de) | 1994-09-07 |
US5698763A (en) | 1997-12-16 |
DE69233477D1 (de) | 2005-03-10 |
DE69233477T2 (de) | 2006-02-16 |
SG47979A1 (en) | 1998-04-17 |
ES2237747T3 (es) | 2005-08-01 |
HK1013841A1 (en) | 1999-09-10 |
EP0613495B1 (de) | 2005-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE288484T1 (de) | Transgene nicht-menschliche tiere ohne prionprotein | |
Manning-Boğ et al. | α-Synuclein overexpression protects against paraquat-induced neurodegeneration | |
Nottoli et al. | AP-2-null cells disrupt morphogenesis of the eye, face, and limbs in chimeric mice | |
Shemer et al. | Structure of the imprinted mouse Snrpn gene and establishment of its parental-specific methylation pattern | |
Gruidl et al. | Multiple potential germ-line helicases are components of the germ-line-specific P granules of Caenorhabditis elegans | |
Pang et al. | AAV-mediated gene therapy for retinal degeneration in the rd10 mouse containing a recessive PDEβ mutation | |
Madison et al. | Cis elements of the villin gene control expression in restricted domains of the vertical (crypt) and horizontal (duodenum, cecum) axes of the intestine | |
Richt et al. | Production of cattle lacking prion protein | |
Varoqueaux et al. | Total arrest of spontaneous and evoked synaptic transmission but normal synaptogenesis in the absence of Munc13-mediated vesicle priming | |
Datto et al. | Targeted disruption of Smad3 reveals an essential role in transforming growth factor β-mediated signal transduction | |
Prather et al. | Genetically engineered pig models for human diseases | |
Orth et al. | Models of Parkinson's disease | |
Zhang et al. | Growth-associated protein GAP-43 and L1 act synergistically to promote regenerative growth of Purkinje cell axons in vivo | |
Ahmad et al. | Genetic screen identifies serpin5 as a regulator of the toll pathway and CHMP2B toxicity associated with frontotemporal dementia | |
Campsall et al. | Characterization of transgene expression and Cre recombinase activity in a panel of Thy‐1 promoter‐Cre transgenic mice | |
Takeda et al. | Microinjection of cytoplasm or mitochondria derived from somatic cells affects parthenogenetic development of murine oocytes | |
Herpin et al. | Inhibition of primordial germ cell proliferation by the medaka male determining gene Dmrt1bY | |
Xu et al. | Protease nexin-2/amyloid β-protein precursor limits cerebral thrombosis | |
ATE315085T1 (de) | Transgene mäuse mit veränderter apolipoprotein e- expression und testverfahren. | |
Trocmé et al. | CRE and TRE sequences of the rat tyrosine hydroxylase promoter are required for TH basal expression in adult mice but not in the embryo | |
Liu et al. | Odd-skipped related-1 controls neural crest chondrogenesis during tongue development | |
Decoville et al. | DSP1, an HMG-like protein, is involved in the regulation of homeotic genes | |
Shen et al. | Efficient generation of P53 biallelic knockout Diannan miniature pigs via TALENs and somatic cell nuclear transfer | |
Krzywinska et al. | Effects of stable ectopic expression of the primary sex determination gene Yob in the mosquito Anopheles gambiae | |
Macieira-Coelho | Biology of aging |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0613495 Country of ref document: EP |